RHHVF
Price
$318.50
Change
-$2.62 (-0.82%)
Updated
Jun 18 closing price
Capitalization
250.69B
35 days until earnings call
SCLX
Price
$4.79
Change
+$0.15 (+3.23%)
Updated
Jun 18 closing price
Capitalization
165.55M
Interact to see
Advertisement

RHHVF vs SCLX

Header iconRHHVF vs SCLX Comparison
Open Charts RHHVF vs SCLXBanner chart's image
Roche Holding
Price$318.50
Change-$2.62 (-0.82%)
Volume$302
Capitalization250.69B
Scilex Holding
Price$4.79
Change+$0.15 (+3.23%)
Volume$53.44K
Capitalization165.55M
RHHVF vs SCLX Comparison Chart in %
Loading...
RHHVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RHHVF vs. SCLX commentary
Jun 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RHHVF is a StrongBuy and SCLX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 19, 2025
Stock price -- (RHHVF: $318.50 vs. SCLX: $4.79)
Brand notoriety: RHHVF and SCLX are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: RHHVF: 2% vs. SCLX: 33%
Market capitalization -- RHHVF: $250.69B vs. SCLX: $165.55M
RHHVF [@Pharmaceuticals: Major] is valued at $250.69B. SCLX’s [@Pharmaceuticals: Major] market capitalization is $165.55M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RHHVF’s FA Score shows that 2 FA rating(s) are green whileSCLX’s FA Score has 0 green FA rating(s).

  • RHHVF’s FA Score: 2 green, 3 red.
  • SCLX’s FA Score: 0 green, 5 red.
According to our system of comparison, RHHVF is a better buy in the long-term than SCLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RHHVF’s TA Score shows that 5 TA indicator(s) are bullish while SCLX’s TA Score has 4 bullish TA indicator(s).

  • RHHVF’s TA Score: 5 bullish, 4 bearish.
  • SCLX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, RHHVF is a better buy in the short-term than SCLX.

Price Growth

RHHVF (@Pharmaceuticals: Major) experienced а -3.05% price change this week, while SCLX (@Pharmaceuticals: Major) price change was -14.31% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.71%. For the same industry, the average monthly price growth was +5.49%, and the average quarterly price growth was +8.52%.

Reported Earning Dates

RHHVF is expected to report earnings on Jul 24, 2025.

SCLX is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.71% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RHHVF($251B) has a higher market cap than SCLX($166M). RHHVF YTD gains are higher at: 13.750 vs. SCLX (-67.904). RHHVF has higher annual earnings (EBITDA): 19.1B vs. SCLX (-109.1M). RHHVF has more cash in the bank: 7.51B vs. SCLX (3.92M). SCLX has less debt than RHHVF: SCLX (128M) vs RHHVF (25.4B). RHHVF has higher revenues than SCLX: RHHVF (60B) vs SCLX (46.7M).
RHHVFSCLXRHHVF / SCLX
Capitalization251B166M151,205%
EBITDA19.1B-109.1M-17,506%
Gain YTD13.750-67.904-20%
P/E Ratio19.34N/A-
Revenue60B46.7M128,480%
Total Cash7.51B3.92M191,507%
Total Debt25.4B128M19,844%
FUNDAMENTALS RATINGS
RHHVF: Fundamental Ratings
RHHVF
OUTLOOK RATING
1..100
89
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
15
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RHHVFSCLX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
29%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
53%
Momentum
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 2 days ago
49%
MACD
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
44%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
31%
Advances
ODDS (%)
Bullish Trend 18 days ago
53%
Bullish Trend 16 days ago
69%
Declines
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
43%
Bearish Trend 2 days ago
34%
Aroon
ODDS (%)
Bullish Trend 2 days ago
49%
Bullish Trend 2 days ago
22%
View a ticker or compare two or three
Interact to see
Advertisement
RHHVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTSDX17.08N/A
N/A
Fidelity Advisor Strategic Div & Inc M
PKAIX13.46N/A
N/A
PIMCO RAE US Instl
RYVIX200.17N/A
N/A
Rydex Energy Services Inv
FGETX23.35N/A
N/A
Fidelity Advisor Glbl Capital Apprec M
GPGOX3.47N/A
N/A
Grandeur Peak Global Opportunities Inv

RHHVF and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHVF has been loosely correlated with RHHBY. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHVF jumps, then RHHBY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHVF
1D Price
Change %
RHHVF100%
-0.82%
RHHBY - RHHVF
65%
Loosely correlated
-1.00%
JNJ - RHHVF
31%
Poorly correlated
-1.08%
NVS - RHHVF
27%
Poorly correlated
-0.39%
AZN - RHHVF
26%
Poorly correlated
-0.30%
RHHBF - RHHVF
25%
Poorly correlated
-0.68%
More

SCLX and

Correlation & Price change

A.I.dvisor tells us that SCLX and BIIB have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCLX and BIIB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCLX
1D Price
Change %
SCLX100%
+3.23%
BIIB - SCLX
22%
Poorly correlated
-0.02%
AMRN - SCLX
20%
Poorly correlated
-0.60%
ABBV - SCLX
10%
Poorly correlated
+0.01%
RHHVF - SCLX
8%
Poorly correlated
-0.82%
NVS - SCLX
6%
Poorly correlated
-0.39%
More